Hologic Exec Awarded 15k Shares in Performance Grant
HOLOGIC INC
Subscribe to track HOLX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Hologic Exec Awarded 15k Shares in Performance Grant
Company: Hologic Inc (HOLX) Form: 4 | Filed: 2025-11-06 Significance: Low
Insider: Verstreken Jan Title: Group President, International | Relationship: Officer
Transaction: • Type: Grant • Shares: 15,196 • Price: $0.00 • Value: $0 • Owned After: 119,010
Key Insight: A routine performance-based stock unit award to a group president, representing a negligible 0.007% of shares outstanding.
Market Context: This grant is part of standard executive compensation and does not signal a new market-moving event for the $16.49B company.
Comprehensive Analysis
SEC Filing Analysis: HOLOGIC INC (HOLX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Hologic's Group President, International, received a routine performance-based stock grant of 15,196 shares as part of their compensation.
- Market Impact: Negligible, as the grant represents a tiny fraction of shares outstanding and is not an open-market transaction.
Company Information
| Field | Value |
|---|---|
| Company | HOLOGIC INC |
| Ticker Symbol | HOLX |
| CIK | 0000859737 |
| Industry | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
Insider Information
| Field | Value |
|---|---|
| Name | Verstreken Jan |
| CIK | 0001829658 |
| Title/Position | Group President, International |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-04 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 15,196 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 119,010 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 15,196 |
| % of Shares Outstanding | 0.007% |
| Post-Transaction Ownership | 119,010 shares (0.054% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction is immaterial against Hologic's $16.49 billion market capitalization.
- Ownership Concentration: The insider's total holding of 0.054% is not a significant stake in the company.
- Dilution Impact: The grant results in a negligible dilution of 0.007% for existing shareholders.
- Transaction Significance: The transaction is considered routine executive compensation with low market significance, as it is an award and not an open-market purchase reflecting new insider sentiment.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a pre-planned, compensation-related stock grant, not an open-market transaction. It does not provide a signal regarding the insider's current view on the company's valuation.
Volume & Sentiment
- Expected Volume Impact: None. This is not an open-market trade and will not affect trading volume.
- Sentiment Indicator: Neutral. Stock grants are a standard part of executive compensation and do not typically influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing footnote indicates these are performance stock units (PSUs) for which performance criteria have been met. The shares are granted at no cost but remain subject to service-based vesting requirements.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
